SCOPIA CAPITAL MANAGEMENT LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 170 filers reported holding PTC THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
SCOPIA CAPITAL MANAGEMENT LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$29,484,000
-33.3%
871,780
-11.3%
1.73%
-12.2%
Q2 2019$44,235,000
-44.2%
983,005
-53.3%
1.96%
-32.9%
Q1 2019$79,277,000
+42.0%
2,106,190
+29.5%
2.93%
+54.6%
Q4 2018$55,837,000
-26.5%
1,626,965
+0.6%
1.89%
+29.5%
Q3 2018$75,999,000
-2.2%
1,616,998
-29.8%
1.46%
+7.7%
Q2 2018$77,692,000
-51.5%
2,303,341
-61.1%
1.36%
-57.6%
Q1 2018$160,034,000
+131.6%
5,914,052
+42.7%
3.20%
+158.2%
Q4 2017$69,110,000
+189.2%
4,143,270
+247.0%
1.24%
+228.0%
Q3 2017$23,895,0001,194,1290.38%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders